PATENT CLAIM ANALYSIS

Application Number: 15754311
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "263220"]

Abstract:
The invention relates generally to compounds of formula (I) that modulate the activity of TGFβR-1 and TGFβR-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.

Claim (Index 12):
The use of a compound according to  claim 1  or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment of diseases or conditions for which a TGF\u03b2R antagonist is indicated.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.41176
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15747843', '14977709', '15746597', '15755636', '12663504']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7997048474083385
- 35 USC 102 Novelty (BERT): 0.5312964099790676
- Combined Prediction Score: 0.7728640036654114
- Mean Citation Score: 308.121634
- Max Citation Score: 358.2882
- Similarity Product: 298.265544539845

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test